Treatment of Anxiety and PTSD in Schizoaffective Disorder

Rationale for SSRI Selection

In adults with major depression and PTSD, SSRIs, particularly sertraline, have been shown to reduce suicidal ideation rather than increase it, according to the American College of Physicians and the American Psychiatric Association 1, 2
The 2024 VA/DoD guidelines suggest offering ketamine infusion for short-term reduction in suicidal ideation, but this is adjunctive and requires specialized administration, as recommended by the Department of Veterans Affairs and the Department of Defense 3

The patient's non-compliance with blood monitoring makes valproate an unsafe option, as stated by the American Academy of Neurology 4
Clozapine is specifically recommended for treatment-resistant schizophrenia/schizoaffective disorder and for patients with substantial ongoing suicide risk despite other treatments, according to the American Psychiatric Association 3, 5
Clozapine requires even more intensive blood monitoring than valproate, making it completely unsuitable for this non-compliant patient, as noted by the American Journal of Psychiatry 1, 5

The 2024 VA/DoD guidelines strongly recommend cognitive behavioral therapy focused on suicide prevention for patients with a history of suicidal behavior, as suggested by the Department of Veterans Affairs and the Department of Defense 3
CBT-based psychotherapy has been shown to reduce suicide attempts by 50% compared to treatment as usual in patients with recent self-directed violence, according to the American College of Physicians and the American Psychiatric Association 1, 3
For PTSD specifically, trauma-focused CBT is the gold standard and should be pursued alongside pharmacotherapy, as recommended by the Department of Veterans Affairs and the Department of Defense 3

The risk of untreated anxiety, PTSD, and suicidal ideation far exceeds the theoretical risk of SSRI-induced suicidality in adults, according to the American College of Physicians and the American Psychiatric Association 1, 2
The black box warning has led to undertreatment of depression and anxiety in many patients who would benefit, as noted by the American Psychiatric Association 2
Always maintain the antipsychotic (risperidone) as the foundation of treatment for schizoaffective disorder, as recommended by the American Psychiatric Association 5
Ensure screening for alcohol and substance use, as these commonly co-occur with schizoaffective disorder and can worsen anxiety, mood lability, and suicidality, according to the American Psychiatric Association 5